Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Serum HE4 concentration was found to be unaffected by the menstrual cycle or hormonal treatments in both endometriosis patients and healthy premenopausal women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- CA 125 in Benign Gynecological Conditions via openalex
- Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis. via openalex
- Fluctuations in CA 125 and CA 15 3 serum concentrations during spontaneous ovulatory cycles via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Serum CA-125 antigen levels increase during menses via openalex
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts via openalex
- The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis via openalex
- The Utility of Human Epididymal Protein 4, Cancer Antigen 125, and Risk for Malignancy Algorithm in Ovarian Cancer and Endometriosis via openalex
- Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex
- Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report via openalex
- W1998846161 via openalex
- W2002852242 via openalex
- W2032557061 via openalex
- W2033057446 via openalex
- W2036740908 via openalex
- W2044032354 via openalex
- W2053056059 via openalex
- W2057601113 via openalex
- W2058484951 via openalex
- W2059947530 via openalex
- W2071667693 via openalex
- W2072755146 via openalex
- W2078301618 via openalex
- W2090081190 via openalex
- W2093252833 via openalex
- W2094347085 via openalex
- W2117275438 via openalex
- W2117354976 via openalex
- W2119642645 via openalex
- W2126233390 via openalex
- W2137634365 via openalex
- W2143628831 via openalex
- W2145803449 via openalex
- W2398473960 via openalex
- W4235294707 via openalex
- W6603012515 via openalex
- W42372792 via openalex
- W59117347 via openalex
- W1716576701 via openalex
- W1968509736 via openalex
- W1985473599 via openalex
- W1990965460 via openalex
- W1992830745 via openalex
- W1995250775 via openalex
- W1997114009 via openalex
Cited by (8)
- The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis 2023
- Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics 2021
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders 2015
- Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125 2015
- The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer 2013
- The Diagnostic Superiority of the HE-4 Marker over CA-125 and CA 19-9 in the Differentiation of a Large Pelvic Tumor – a Case Report 2013
- Circulating MicroRNAs Identified in a Genome-Wide Serum MicroRNA Expression Analysis as Noninvasive Biomarkers for Endometriosis 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:17.081435+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK